Additionally, Gerber et al. 56 have shown that a higher Il-2 level in the tumour microenvironment enhances the number of IFN-γ-producing CD8+ T-cells, which attenuate B16 melanoma growth and stimulate cellular dormancy. The gene discussed is CD8A; the disease is neoplasm.